Lipella Pharmaceuticals Inc. Cash Equivalents, at Carrying Value
Lipella Pharmaceuticals Inc. (LIPO) had Cash Equivalents, at Carrying Value of $1.73 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2025-11-14
- 2025-09-30: Cash Equivalents, at Carrying Value $1.73M.
- 2025-06-30: Cash Equivalents, at Carrying Value $2.63M.
- 2025-03-31: Cash Equivalents, at Carrying Value $4.12M.
- 2024-12-31: Cash Equivalents, at Carrying Value $1.69M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-09-30 | $1.73M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.63M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $4.12M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.69M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $1.25M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $871.20K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.98M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.05M 10-K · filed 2025-03-28 |
| 2023-09-30 | $2.09M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.80M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.71M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $709.34K 10-K · filed 2023-03-31 |